Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001140361-16-047642)

Filing Details

Accession Number:
0001140361-16-047642
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-12 17:02:31
Reporting Period:
2016-01-11
Filing Date:
2016-01-12
Accepted Time:
2016-01-12 17:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082038 Durect Corp DRRX Pharmaceutical Preparations (2834) 943297098
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457518 First Eagle Value In Biotechnology Master Fund, Ltd. Citco Fund Services (Cayman Islands) Ltd
Regatta Office Park West Bay Road
Grand Cayman E9 KY1-1205		 No No Yes No
1459688 21 April Fund Lp First Eagle Investment Management, Llc
1345 Avenue Of The Americas, 44Th Floor
New York NY 10105		 No No Yes No
1459708 Ltd Fund April 21 Citco Fund Services (Cayman Islands) Ltd
Regatta Office Park West Bay Road
Grand Cayman E9 KY1-1205		 No No Yes No
1637141 Arnhold & S. Bleichroeder Holdings, Inc. 1345 Avenue Of The Americas
New York NY 10105		 No No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-11 300,100 $1.37 14,381,546 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents 61,311 and 238,789 shares purchased by 21 April Fund, LP ("21 April LP") and 21 April Fund, Ltd. ("21 April Ltd."), respectively. First Eagle Investment Management, LLC ("FEIM") is (i) a general partner of 21 April LP, (ii) the registered investment adviser to First Eagle Value in Biotechnology Master Fund, Ltd. "FEVIBM" as well as to 21 April LP and 21 April Ltd. (collectively, the "Funds") and (iii) a subsidiary of Arnhold and S. Bleichroeder Holdings, Inc. ("ASBH"). ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.
  2. Represents 1,997,606, 7,296,996, and 5,086,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. ASBH disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that ASBH is the Section 16 beneficial owner of any such securities.